To confirm a similar distribution of FOXC1 binding sites in Fujioka cells by comparison with primary patient blast cells, we performed FOXC1 ChIP-seq in a normal karyotype AML sample (BB475; Table S1); MACS2 identified 39,941 FOXC1 peaks. The gene discussed is ACSM2A; the disease is acute myeloid leukemia.